Guizhou Xinbang Pharmaceutical Co., Ltd. (SHE:002390)

Market Cap	6.20B -24.1%
Revenue (ttm)	5.73B -7.6%
Net Income	77.12M -64.5%
EPS	0.04 -66.9%
Shares Out	1.90B
PE Ratio	85.72
Forward PE	n/a
Dividend	0.06 (1.79%)
Ex-Dividend Date	Sep 26, 2025

Volume	24,650,002
Average Volume	27,709,263
Open	3.350
Previous Close	3.270
Day's Range	3.210 - 3.350
52-Week Range	3.140 - 4.150
Beta	0.33
RSI	41.99
Earnings Date	Apr 21, 2026

About SHE:002390

Guizhou Xinbang Pharmaceutical Co., Ltd. manufactures and sells traditional Chinese medicine and other pharmaceutical products in China and internationally. The company cardiovascular and cerebrovascular, digestive system, endocrine, tumors and immunomodulatory drugs, blood system drugs, rheumatism and rheumatoid arthritis, urinary system, antipyretic and analgesic, cold medicine, gynecological medications, and anti-infective drugs. It also provides medical services. The company was founded in 1995 and is headquartered in Guiyang, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1995
• Employees: 5,059
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002390

Financial Performance

In 2024, SHE:002390's revenue was 6.03 billion, a decrease of -6.63% compared to the previous year's 6.46 billion. Earnings were 101.38 million, a decrease of -64.70%.